Clicky

KEMPHARM INC. DL-0001(1GDA) News

Date Title
Jul 18 Zevra Therapeutics Announces MIPLYFFA® and OLPRUVA® Presentations at the Annual Meeting of the Southeastern Regional Genetics Group (SERGG)
Jul 17 Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics
Jul 16 Are You Looking for a Top Momentum Pick? Why Zevra Therapeutics (ZVRA) is a Great Choice
Jul 16 Zevra Therapeutics Announces Open Label Extension Data Showing Sustained Long-Term Efficacy of MIPLYFFA for the Treatment of NPC Published in the Journal of Molecular Genetics and Metabolism
Jul 15 Wall Street Analysts Predict an 86.55% Upside in Zevra Therapeutics (ZVRA): Here's What You Should Know
Jul 15 Here's Why 'Trend' Investors Would Love Betting on Zevra Therapeutics (ZVRA)
Jul 11 Zevra Therapeutics Announces MIPLYFFA® (arimoclomol) Featured in Presentations at the National Niemann Pick Disease Foundation Conference
May 29 Zevra Announces Final Results of 2025 Annual Meeting of Stockholders
May 27 Citizens JMP Reiterates Buy Rating on Zevra Therapeutics (ZVRA), Keeps PT